4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001567619-23-001163
Chief Executive Officer sold 19,524 shares at an average $20.10 ($392,474)
From the SEC's structured data for this filing
Trades in this filing
Kirn David · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-01-19 | Sale : show line 1 in the form | −10,899 | $20.03 | $218,347 | 1,902,224 | D |
| 2023-01-20 | Sale : show line 2 in the form | −8,625 | $20.19 | $174,127 | 1,893,599 | D |
| Open-market sales · 19,524 sh · avg $20.10 · $392,474 | ||||||
Loading xslF345X03/doc1.xml…